ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.34
0.51%
US Tech 100
19,742.00
0.47%
S&P 500
5,841.47
-0.02%
US Dollar vs CAD
1.37938
-0.02%
Bitcoin
67,775.02
0.53%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Centessa Pharmaceuticals Plc (0ACX) Share Price

Centessa Pharmaceuticals Plc

Centessa Pharmaceuticals Plc (0ACX)

LSE
0.00
0.00
( 0.00% )
Updated: -
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
-
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
0.00
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
6.85M
Net Profit
-151.09M

About Centessa Pharmaceuticals Plc

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.centessa.com
Headquarters
Cheshire, Gbr
Founded
-
Centessa Pharmaceuticals Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker 0ACX. The last closing price for Centessa Pharmaceuticals was -. Over the last year, Centessa Pharmaceuticals shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Centessa Pharmaceuticals currently has 0 shares outstanding.

Ask ADVFN Intelligence (AI)

0ACX Latest News

More News

Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares

Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares BOSTON and LONDON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals...

September 12 2024
UK Regulatory

Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares

Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares BOSTON and LONDON, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq:...

September 11 2024
UK Regulatory

Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers

Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers 2.5 mg dose restored normative...

September 10 2024
UK Regulatory

Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)

Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep...

August 27 2024
UK Regulatory

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024 Company advancing pipeline of potential best-in-class orexin receptor 2 (OX2R) agonists...

August 13 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MTCMothercare Plc
4.90p
(37.64%)
2.85M
WSBNWishbone Gold Plc
0.375p
(25.00%)
6.43M
PRIMPrimorus Investments Plc
4.25p
(21.43%)
502.39k
HEMOHemogenyx Pharmaceuticals Plc
1.35p
(21.18%)
18.73M
TRLSTrellus Health Plc
0.75p
(19.05%)
436.72k
FUTRFuture Plc
834.50p
(-15.19%)
1.01M
NFXNuformix Plc
0.055p
(-12.00%)
820.13k
JADEJade Road Investments Limited
0.175p
(-11.62%)
39.22k
AFCAfc Energy Plc
7.10p
(-9.21%)
5.28M
MNRGMetalnrg Plc
0.50p
(-9.09%)
67.55M
MSMNMosman Oil And Gas Limited
0.054p
(9.31%)
452.77M
TRPTower Resources Plc
0.0295p
(-3.28%)
227.45M
DKEDukemount Capital Plc
0.035p
(4.48%)
189.92M
NTVONativo Resources Plc
0.0026p
(0.00%)
150.17M
PREMPremier African Minerals Limited
0.0435p
(-5.43%)
131.73M

Discussion

View Full Feed
TrendTrade2016 TrendTrade2016 4 minutes ago
I TAUGHT THE S&P BOARD CLOWNS LAST YEAR ABOUT VOLATILITY AND THAT IT PROCEEDS FORWARD MOTION
JDZG
JusticeWillWin JusticeWillWin 4 minutes ago
🚀💥🚀$COOP price targets==>UBS:$118, Wedbush:$115, Barclays:$108, KBW:$105, Piper Sandler:$103, Compass Point:$97, DEUTSCHE BANK:$90
COOP UBS
tw0122 tw0122 4 minutes ago
HEPS $3.70 + 70% flipping out now
HEPS
JusticeWillWin JusticeWillWin 5 minutes ago
👉👉👉Only 3 BUSINESS DAYS until COOP Q3 earnings on October 23 (pre-market)

See: https://www.businesswire.com/news/home/20241008316039/en/Mr.-Cooper-Group-Inc.-to-Discuss-Third-Quarter-2024-Financial-Results-on-October-23-2024
COOP
tw0122 tw0122 6 minutes ago
JDZG 3.27 +90% nice ongoing flip action
JDZG
buysellrepeat buysellrepeat 7 minutes ago
Yeah it will. I expect to see at least a $20M market cap by this time next year.
ATWT
stockinspector stockinspector 7 minutes ago
People might want to tune into their gut feelings. That is 10,000
years worth of evolution trying to tell you something.
WDLF
TrendTrade2016 TrendTrade2016 7 minutes ago
EXPLOSION
JDZG
sirant sirant 8 minutes ago
GOOD MORNING EVERYONE 

GO $MCIC 
MCIC
StonkMaster StonkMaster 8 minutes ago
List has been updated, no NWBO, shocker :)

style="font-size: 16px"https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2024?utm_medium=email&utm_campaign=govuk-notifications-single-page&utm_source=6ca07490-02f2-467d-ba11-3e542f2b9b18&utm_content=immediately
NWBO
TRUISM TRUISM 9 minutes ago
While it's a plus to be enthusiastic in what one has invested in, I find it prudent to curb ones

expectations; especially when it comes to OTC companies that research and develop

specific technologies, with the goal of eventually bringing their "product to market."
KBLB
tw0122 tw0122 10 minutes ago
$3.10 +40% The aggregate consideration for the transaction is approximately $1,127 million, payable in cash in two installments. The transaction is subject to customary closing conditions and regulatory approvals in Türkiye, with closing expected in the first quarter 2025.

Mikheil Lom
HEPS
Jrod301 Jrod301 11 minutes ago
Could she go Sub-SubPenny? What does David know about Gaming? I guess nothing. FKH
GMER
uranium-pinto-beans uranium-pinto-beans 11 minutes ago
KSPI, HEPS
Kaspi.kz to acquire 65.41% of Hepsiburada for $1.13B
Kaspi.kz (KSPI) has announced that it has signed a definitive agreement with Hanzade Dogan, the founder and controlling shareholder of Hepsiburada (HEPS), and Vuslat Dogan Sabanci, Begum Dogan Faralyali, Arzuhan Dogan Y
floblu14 floblu14 11 minutes ago
Docket last updated: 5 hours ago

Thursday, October 17, 2024
381 misc Stipulation Thu 10/17 2:59 PM
STIPULATION and PROPOSED ORDER regarding the Deposition of Mr. John Wichtowski by Enanta Pharmaceuticals, Inc.. (Fiacco, Barbara)

John Wichtowski
As
ENTA
TrendTrade2016 TrendTrade2016 13 minutes ago
MY EYES ARE BAD WEEKLY SAR NOW HITTING...VSME DID THE SAME THING
VSME
ipo_dude ipo_dude 14 minutes ago
Old news recycled over and over
TNON
NickyCapone NickyCapone 15 minutes ago
Illegal short buying is doomed
AMC
dukeb dukeb 17 minutes ago
Rory and Meltzer's GoFundYourself show seems to be involved with some shady characters. Who could have possibly predicted that?

The most recent GFY episode is a guy who started a company called Fundify that...wait for it...funds startups.

So the original mission of GF
VERB
capgain capgain 17 minutes ago
He was, I watched it last night. I'm not usually up that late, but decided to take a nap yesterday afternoon.
TrendTrade2016 TrendTrade2016 18 minutes ago
HERE COMES THE WEEKLY SAR TEST
JDZG
floblu14 floblu14 18 minutes ago
FWIW -
Millennium Management LLC's Strategic Acquisition of Enanta Pharmaceuticals Shares - October 17

On September 30, 2024, Millennium Management LLC, a prominent hedge fund, expanded its investment portfolio by acquiring 73,1295 shares of Enanta Pharmaceuticals Inc (NASDAQ:E
ENTA
ipo_dude ipo_dude 18 minutes ago
Im out
SOBR

Your Recent History

LSE
0ACX
Centessa Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved